Eroglu Z, Kim Y, Gibney G, et al. Mature results of combination nivolumab (NIVO) plus ipilimumab (IPI) as adjuvant therapy in stage IIIC/IV melanoma (MEL). SMR 2017, abstract SMR09-06.
pCR bij gereseceerd pancreasadenocarcinoom na preoperatieve chemo(radio)therapie
sep 2024 | Maag-darm-leveroncologie